FDA has not assured peptide identity or purity regarding a matter involving Mount Sinai.
1 report, 1 independent
Updated Sep 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA has not assured peptide identity or purity regarding a matter involving Mount Sinai.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Mount Sinai
hamlet located within the Town of Brookhaven in Suffolk County, New York, United States
Nothing else this week.
Related events
- HHS policy changes regarding peptide access are affecting Olympia's facility.
- HHS policy allows peptides in compounding pharmacies despite FDA lack of approval, with RFK Jr. arguing for safer compounds.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.